Kidswell Bio Corporation (TYO:4584)
250.00
-1.00 (-0.40%)
Apr 17, 2026, 3:30 PM JST
Kidswell Bio Market Cap
Kidswell Bio has a market cap or net worth of 12.4 billion as of April 17, 2026. Its market cap has increased by 130.88% in one year.
Market Cap
12.40B
Enterprise Value
11.24B
Revenue
7.06B
Ranking
n/a
PE Ratio
517.43
Stock Price
250.00
Market Cap Chart
Since November 30, 2012, Kidswell Bio's market cap has increased from 2.73B to 12.40B, an increase of 353.78%. That is a compound annual growth rate of 11.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 12.40B | 23.18% |
| Dec 30, 2025 | 10.07B | 125.16% |
| Dec 30, 2024 | 4.47B | -11.75% |
| Dec 29, 2023 | 5.07B | -40.50% |
| Dec 30, 2022 | 8.52B | -45.05% |
| Dec 30, 2021 | 15.50B | 7.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ReproCELL | 17.11B |
| CanBas | 14.22B |
| Immuno-Biological Laboratories | 14.06B |
| Nano Holdings | 12.06B |
| CellSeed | 11.47B |
| Kubota Pharmaceutical Holdings | 11.19B |
| OncoTherapy Science | 10.36B |
| K Pharma,Inc. | 8.80B |